The news on Eli Lilly
There has been 284 news on Eli Lilly in the past from 25 different sources and amongst 3 sections.
Full access to all news in this scope:
See the trend on this scope:
Evolution through time
Latest news
From pills to new uses, here's what Eli Lilly's top scientist sees as the future of weight loss drugs
Eli Lilly aims to invest in 'big problems hiding in plain sight' using obesity windfall
Eli Lilly wants to use its weight loss drug windfall to fight Alzheimer's and hearing loss
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Eli Lilly beats on earnings even as weight loss, diabetes drug sales fall short
Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024
Eli Lilly has its mojo back ahead of a pivotal year for the obesity drug giant
Eli Lilly expects to beat profit forecasts on obesity drug demand
Eli Lilly must put to rest doubts about whether Zepbound's growth can live up to the hype
Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand
Eli Lilly shares fall after revenue miss for blockbuster weight-loss drugs
Eli Lilly CEO expects new weight loss pill to be approved next year
Eli Lilly was hoping weight loss drug demand would be even bigger
Eli Lilly Cuts Sales Outlook After Sluggish Growth for Incretin Drugs
Eli Lilly's lead in the obesity race has grown. Its recent stock performance says otherwise
Eli Lilly's weight loss pill could get federal approval by early next year
Eli Lilly to buy Scorpion Therapeutics' cancer therapy for up to $2.5 billion
Eli Lilly's new GCC to boost digital strategy & innovation
Sections
The coverage spreads amongst 3 sections:
Sources
There has been 25 news sources reporting on this, including: CNBC News (43%), Quartz (16%), The Wall Street Journal (10%), Financial Times (8%), NBC News (4%).
Going further
Stay up to date:
Details
This content can be used under the CC BY 4.0 license